Heron Therapeutics Inc

NASDAQ:HRTX   10:02:09 AM EDT
8.75
+0.07 (+0.81%)
Products

Heron Therapeutics Announces Submission Of HTX-019 NDA For The Prevention Of Postoperative Nausea And Vomiting To FDA

Published: 11/18/2021 12:45 GMT
Heron Therapeutics Inc (HRTX) - Heron Therapeutics Announces Submission of Htx-019 NDA for the Prevention of Postoperative Nausea and Vomiting to FDA.